title: Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortality.
abstract: Obesity affects multiple points along the breast cancer control continuum from prevention to screening and treatment, often in opposing directions. Obesity is also more prevalent in Blacks than Whites at most ages so it might contribute to observed racial disparities in mortality. We use two established simulation models from the Cancer Intervention and Surveillance Modeling Network (CISNET) to evaluate the impact of obesity on race-specific breast cancer outcomes. The models use common national data to inform parameters for the multiple US birth cohorts of Black and White women, including age- and race-specific incidence, competing mortality, mammography characteristics, and treatment effectiveness. Parameters are modified by obesity (BMI of ≥ 30 kg/m(2)) in conjunction with its age-, race-, cohort- and time-period-specific prevalence. We measure age-standardized breast cancer incidence and mortality and cases and deaths attributable to obesity. Obesity is more prevalent among Blacks than Whites until age 74; after age 74 it is more prevalent in Whites. The models estimate that the fraction of the US breast cancer cases attributable to obesity is 3.9-4.5 % (range across models) for Whites and 2.5-3.6 % for Blacks. Given the protective effects of obesity on risk among women <50 years, elimination of obesity in this age group could increase cases for both the races, but decrease cases for women ≥ 50 years. Overall, obesity accounts for 4.4-9.2 % and 3.1-8.4 % of the total number of breast cancer deaths in Whites and Blacks, respectively, across models. However, variations in obesity prevalence have no net effect on race disparities in breast cancer mortality because of the opposing effects of age on risk and patterns of age- and race-specific prevalence. Despite its modest impact on breast cancer control and race disparities, obesity remains one of the few known modifiable risks for cancer and other diseases, underlining its relevance as a public health target.
authors.affiliation: Cancer Prevention and Control Program, Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3300 Whitehaven Street, Suite 4100, Washington, DC 20007, USA.
authors.forename: Yaojen
authors.initials: Y
authors.lastname: Chang
authors.forename: Clyde B
authors.initials: CB
authors.lastname: Schechter
authors.forename: Nicolien T
authors.initials: NT
authors.lastname: van Ravesteyn
authors.forename: Aimee M
authors.initials: AM
authors.lastname: Near
authors.forename: Eveline A M
authors.initials: EA
authors.lastname: Heijnsdijk
authors.forename: Lucile
authors.initials: L
authors.lastname: Adams-Campbell
authors.forename: David
authors.initials: D
authors.lastname: Levy
authors.forename: Harry J
authors.initials: HJ
authors.lastname: de Koning
authors.forename: Jeanne S
authors.initials: JS
authors.lastname: Mandelblatt
mesh_terms: D000328:Adult; D001741:Black or African American; D000368:Aged; D001943:Breast Neoplasms / Q000000981:diagnostic imaging / Q000453:epidemiology* / Q000401:mortality / Q000628:therapy; D003198:Computer Simulation; D005260:Female; D006801:Humans; D008327:Mammography; D008875:Middle Aged; D015233:Models, Statistical; D009765:Obesity / Q000150:complications / Q000453:epidemiology* / Q000401:mortality; D018426:SEER Program; D014481:United States / Q000453:epidemiology; D044465:White People